Duke University

Mobile health intervention to improve physical activity, quality of life and metabolomic profiles in patients with HF and diabetes.

CV events with degarelix (Firmagon, Ferring Pharmaceuticals) or leuprolide in patients with advanced prostate cancer and CVD.

More than 50% of cardiologists from historically underrepresented racial or ethnic groups reported experiencing discrimination during their career, according to results from a survey.

Many misconceptions about the ketogenic diet are spread on the internet, an expert told attendees at the Obesity Medicine Association fall conference.

A 4-month cardiac rehab program for treatment-resistant hypertension focused on diet, exercise and weight loss conferred greater improvement in both in-office and 24-hour ambulatory BP compared with a single educational session.

A mobile health intervention that included texts with feedback and updated personalized physical activity goals improved physical activity, quality of life and metabolomic profiling in patients with HF and diabetes, a speaker reported.

Compared with the usual care alone, a mobile app intervention plus the usual care may improve HF quality of care by improving patients’ own self-care after hospitalization for acute HF, a speaker reported.

In the PRONOUNCE trial, which aimed to compare the CV safety of androgen deprivation therapies for prostate cancer, there was no difference in major adverse CV events at 1 year among adults with prostate cancer and atherosclerotic CVD.

Patients with head and neck cancer who reside in rural areas appeared five times more likely to commit suicide than the general population, according to study results published in JAMA Otolaryngology-Head & Neck Surgery.

Rivaroxaban (Xarelto, Janssen/Bayer)-based therapeutic anticoagulation vs. standard of care in patients with COVID-19.